Home Biogen Idec wins Canadian approval for hemophilia drug Alprolix
 

Keywords :   


Biogen Idec wins Canadian approval for hemophilia drug Alprolix

2014-03-21 15:39:52| Biotech - Topix.net

Hemophilia B, a rare inherited disorder in which the ability of a person's blood to clot is impaired, affects some 4,000 people in the United States and roughly 25,000 worldwide.

Tags: drug approval canadian wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
16.11HestraFallLine3
16.11GBA
16.11 SKY PAD 3.0 XL
16.1125th
16.112022taxDVD
16.11
16.11
16.11 e
More »